Precigen, Inc. (PGEN)
4.52
-0.14
(-3.00%)
USD |
NASDAQ |
Nov 13, 16:00
4.52
0.00 (0.00%)
After-Hours: 19:59
Precigen Total Assets (Quarterly) : 212.10M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 212.10M |
| June 30, 2026 | 170.30M |
| March 31, 2026 | 138.63M |
| December 31, 2025 | 156.62M |
| September 30, 2025 | 171.26M |
| June 30, 2025 | 101.90M |
| March 31, 2025 | 128.79M |
| December 31, 2024 | 146.54M |
| September 30, 2024 | 83.47M |
| June 30, 2024 | 73.16M |
| March 31, 2024 | 134.85M |
| December 31, 2023 | 160.14M |
| September 30, 2023 | 190.69M |
| June 30, 2023 | 207.53M |
| March 31, 2023 | 241.55M |
| December 31, 2022 | 225.15M |
| September 30, 2022 | 259.24M |
| June 30, 2022 | 321.22M |
| March 31, 2022 | 335.57M |
| December 31, 2021 | 375.86M |
| September 30, 2021 | 376.90M |
| June 30, 2021 | 402.57M |
| March 31, 2021 | 406.98M |
| December 31, 2020 | 324.30M |
| September 30, 2020 | 336.19M |
| Date | Value |
|---|---|
| June 30, 2020 | 361.72M |
| March 31, 2020 | 404.67M |
| December 31, 2019 | 471.01M |
| September 30, 2019 | 604.90M |
| June 30, 2019 | 655.19M |
| March 31, 2019 | 709.86M |
| December 31, 2018 | 724.61M |
| September 30, 2018 | 980.42M |
| June 30, 2018 | 825.15M |
| March 31, 2018 | 895.67M |
| December 31, 2017 | 846.85M |
| September 30, 2017 | 898.26M |
| June 30, 2017 | 933.99M |
| March 31, 2017 | 915.93M |
| December 31, 2016 | 949.07M |
| September 30, 2016 | 1.006B |
| June 30, 2016 | 1.031B |
| March 31, 2016 | 962.43M |
| December 31, 2015 | 982.05M |
| September 30, 2015 | 989.89M |
| June 30, 2015 | 792.94M |
| March 31, 2015 | 819.99M |
| December 31, 2014 | 576.27M |
| September 30, 2014 | 538.50M |
| June 30, 2014 | 500.54M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 189.60M |
| Aldeyra Therapeutics, Inc. | 43.38M |
| Repligen Corp. | 2.926B |
| AC Immune SA | 166.73M |
| Inovio Pharmaceuticals, Inc. | 60.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 128.31M |
| Shareholders Equity (Quarterly) | 83.79M |
| Debt to Equity Ratio | 1.177 |
| Current Ratio | 5.579 |
| Net Debt Paydown Yield | -0.61% |